| Products |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
| Cell Signaling Pathway Inhibitors |
Now Position:Home > Products > Cell Signaling Pathway Inhibitors < Inhibitors of VEGFR pathways |
|
| Brivanib; BMS-540215(CAS:649735-46-6) |
 |
|
|
Product No.
|
|
TP1048A
|
|
Name
|
|
Brivanib
|
|
Synonyms
|
|
BMS-540215
|
|
CAS Number
|
|
649735-46-6
|
|
Structure
|
|
|
|
Brief Description
|
|
Brivanib is an ATP-competitive inhibitor against human VEGFR2 and FGFR with IC50 of 25 nM and 148 nM, respectively.
|
|
Purity
|
|
>99%
|
|
Package
|
|
5mg, 10mg, 20mg, 50mg
|
|
|
|
|
|
|
